Takeshi Iwatsubo, MD, PhD

Professor of neuropathology at the University of Tokyo School of Medicine.

Articles by Takeshi Iwatsubo, MD, PhD

Early Clinical Use of Anti-Amyloid Therapy for Alzheimer Disease in Japan: Takeshi Iwatsubo, MD, PhD

November 8th 2024

The professor of neuropathology at the University of Tokyo School of Medicine talked about the latest data on lecanemab use in clinical practice for Alzheimer disease in Japan presented at CTAD 2024. [WATCH TIME: 4 minutes]

Latest Updated Articles

Takeshi Iwatsubo, MD, PhD

Articles by Takeshi Iwatsubo, MD, PhD

Early Clinical Use of Anti-Amyloid Therapy for Alzheimer Disease in Japan: Takeshi Iwatsubo, MD, PhD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related related Amyloid Pathology

Understanding Ocrelizumab’s Impact on Advanced Progressive MS: Insights From Dr. Gavin Giovannoni

Trofinetide Leads to Real-World Improvements in Rett Syndrome Symptoms, LOTUS Study Finds

FDA Delays Review Deadline for Hunter Syndrome Agent Tividenofusp Alfa

Overviewing Phase 3 OPERETTA 2 Trial and Ocrelizumab’s Impact on Pediatric Multiple Sclerosis: Brenda Banwell, MD, FRCPC, FAAN